Table 3.
The results of the log-rank test
| Variables | Total | <60 | ≥ 60 |
|---|---|---|---|
| Age | < 0.001 | ||
| <60 | |||
| ≥ 60 | |||
| Year of diagnosis | 0.006 | 0.329 | 0.035 |
| 1992–2002 | |||
| 2003–2012 | |||
| 2013–2018 | |||
| Sex | 0.757 | 0.4 | 0.794 |
| Male | |||
| Female | |||
| Race | 0.188 | 0.091 | 0.785 |
| White | |||
| Others | |||
| Laterality | 0.05 | 0.03 | 0.072 |
| Unilateral | |||
| Bilateral | |||
| Unknown | |||
| Primary site | 0.002 | 0.946 | 0.018 |
| Retina | |||
| Choroid | |||
| Ciliary body | |||
| Vitreous | |||
| Pathological type | < 0.001 | 0.347 | < 0.001 |
| DLBCL | |||
| MALT | |||
| NHL, NOS | |||
| Other/unclassifiedb | |||
| Ann arbor stage | 0.057 | 0.22 | 0.032 |
| I to II | |||
| III to IV | |||
| Unknown | |||
| Surgery | 0.44 | 0.949 | 0.521 |
| NO | |||
| Performed | |||
| Radiotherapy | 0.361 | 0.147 | 0.715 |
| No/unknown | |||
| Performed | |||
| Chemotherapy | < 0.001 | 0.001 | 0.001 |
| No/unknown | |||
| Performed |